Literature DB >> 16174657

Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice.

K Tomita1, G Tamiya, S Ando, K Ohsumi, T Chiyo, A Mizutani, N Kitamura, K Toda, T Kaneko, Y Horie, J-Y Han, S Kato, M Shimoda, Y Oike, M Tomizawa, S Makino, T Ohkura, H Saito, N Kumagai, H Nagata, H Ishii, T Hibi.   

Abstract

BACKGROUND: While tumour necrosis factor alpha (TNF-alpha) appears to be associated with the development of non-alcoholic steatohepatitis (NASH), its precise role in the pathogenesis of NASH is not well understood.
METHODS: Male mice deficient in both TNF receptors 1 (TNFR1) and 2 (TNFR2) (TNFRDKO mice) and wild-type mice were fed a methionine and choline deficient (MCD) diet or a control diet for eight weeks, maintaining isoenergetic intake.
RESULTS: MCD dietary feeding of TNFRDKO mice for eight weeks resulted in attenuated liver steatosis and fibrosis compared with control wild-type mice. In the liver, the number of activated hepatic Kupffer cells recruited was significantly decreased in TNFRDKO mice after MCD dietary feeding. In addition, hepatic induction of TNF-alpha, vascular cell adhesion molecule 1, and intracellular adhesion molecule 1 was significantly suppressed in TNFRDKO mice. While in control animals MCD dietary feeding dramatically increased mRNA expression of tissue inhibitor of metalloproteinase 1 (TIMP-1) in both whole liver and hepatic stellate cells, concomitant with enhanced activation of hepatic stellate cells, both factors were significantly lower in TNFRDKO mice. In primary cultures, TNF-alpha administration enhanced TIMP-1 mRNA expression in activated hepatic stellate cells and suppressed apoptotic induction in activated hepatic stellate cells. Inhibition of TNF induced TIMP-1 upregulation by TIMP-1 specific siRNA reversed the apoptotic suppression seen in hepatic stellate cells.
CONCLUSIONS: Enhancement of the TNF-alpha/TNFR mediated signalling pathway via activation of Kupffer cells in an autocrine or paracrine manner may be critically involved in the pathogenesis of liver fibrosis in this NASH animal model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16174657      PMCID: PMC1856073          DOI: 10.1136/gut.2005.071118

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  Common pathogenic mechanisms in ASH and NASH.

Authors:  Hiromasa Ishii
Journal:  Hepatol Res       Date:  2004-01       Impact factor: 4.288

Review 2.  The TNF ligand superfamily and its relevance for human diseases.

Authors:  H J Gruss; S K Dower
Journal:  Cytokines Mol Ther       Date:  1995-06

3.  Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice.

Authors:  M Yin; M D Wheeler; H Kono; B U Bradford; R M Gallucci; M I Luster; R G Thurman
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

4.  Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats.

Authors:  Michio Imamura; Tadashi Ogawa; Yasuyuki Sasaguri; Kazuaki Chayama; Hikaru Ueno
Journal:  Gastroenterology       Date:  2005-01       Impact factor: 22.682

5.  Induction of hepatic stellate cell proliferation by LPS-stimulated peripheral blood mononuclear cells from patients with liver cirrhosis.

Authors:  K Toda; N Kumagai; K Tsuchimoto; H Inagaki; T Suzuki; T Oishi; K Atsukawa; H Saito; T Morizane; T Hibi; H Ishii
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

6.  Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat.

Authors:  Y Iimuro; R M Gallucci; M I Luster; H Kono; R G Thurman
Journal:  Hepatology       Date:  1997-12       Impact factor: 17.425

Review 7.  Early events in TNF signaling: a story of associations and dissociations.

Authors:  B G Darnay; B B Aggarwal
Journal:  J Leukoc Biol       Date:  1997-05       Impact factor: 4.962

8.  Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats.

Authors:  Christopher J Parsons; Blair U Bradford; Clark Q Pan; Ellen Cheung; Michael Schauer; Andreas Knorr; Barbara Krebs; Sabine Kraft; Stefan Zahn; Bodo Brocks; Nikki Feirt; Baisong Mei; Myung-Sam Cho; Roopa Ramamoorthi; Greg Roldan; Paul Ng; Peggy Lum; Claudia Hirth-Dietrich; Adrian Tomkinson; David A Brenner
Journal:  Hepatology       Date:  2004-11       Impact factor: 17.425

9.  Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine.

Authors:  Enrique Santamaria; Matías A Avila; M Ujue Latasa; Angel Rubio; Antonio Martin-Duce; Shelly C Lu; José M Mato; Fernando J Corrales
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-11       Impact factor: 11.205

10.  Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met.

Authors:  Kengo Tomita; Toshifumi Azuma; Naoto Kitamura; Jiro Nishida; Gen Tamiya; Akira Oka; Sayaka Inokuchi; Takeshi Nishimura; Makoto Suematsu; Hiromasa Ishii
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682

View more
  144 in total

1.  Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.

Authors:  Allyson K Martínez; Luca Maroni; Marco Marzioni; Syed T Ahmed; Mena Milad; Debolina Ray; Gianfranco Alpini; Shannon S Glaser
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

Review 2.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease.

Authors:  Thomas A Wynn; Thirumalai R Ramalingam
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

3.  TNFα in liver fibrosis.

Authors:  Yoon Mee Yang; Ekihiro Seki
Journal:  Curr Pathobiol Rep       Date:  2015-09-30

Review 4.  Inflammation and fibrogenesis in steatohepatitis.

Authors:  Hideki Fujii; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2012-02-07       Impact factor: 7.527

5.  Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice.

Authors:  Justin R Henning; Christopher S Graffeo; Adeel Rehman; Nina C Fallon; Constantinos P Zambirinis; Atsuo Ochi; Rocky Barilla; Mohsin Jamal; Michael Deutsch; Stephanie Greco; Melvin Ego-Osuala; Usama Bin-Saeed; Raghavendra S Rao; Sana Badar; Juan P Quesada; Devrim Acehan; George Miller
Journal:  Hepatology       Date:  2013-06-24       Impact factor: 17.425

Review 6.  Host responses in tissue repair and fibrosis.

Authors:  Jeremy S Duffield; Mark Lupher; Victor J Thannickal; Thomas A Wynn
Journal:  Annu Rev Pathol       Date:  2012-10-22       Impact factor: 23.472

7.  Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice.

Authors:  James P Luyendyk; Bradley P Sullivan; Grace L Guo; Ruipeng Wang
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

8.  Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.

Authors:  Michitaka Matsuda; Ekihiro Seki
Journal:  Semin Liver Dis       Date:  2020-04-02       Impact factor: 6.115

Review 9.  Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.

Authors:  Jacquelyn J Maher; Pablo Leon; James C Ryan
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

10.  NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL-17 and TNF in mice.

Authors:  Alexander Wree; Matthew D McGeough; Maria Eugenia Inzaugarat; Akiko Eguchi; Susanne Schuster; Casey D Johnson; Carla A Peña; Lukas J Geisler; Bettina G Papouchado; Hal M Hoffman; Ariel E Feldstein
Journal:  Hepatology       Date:  2017-12-28       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.